Literature DB >> 25469855

5β,19-epoxycucurbitane triterpenoids from Momordica charantia and their anti-inflammatory and cytotoxic activity.

Chia-Ching Liaw1, Hui-Chi Huang2, Ping-Chun Hsiao3, Li-Jie Zhang3, Zhi-Hu Lin3, Syh-Yuan Hwang4, Feng-Lin Hsu5, Yao-Haur Kuo3.   

Abstract

Five new 5β,19-epoxycucurbitane triterpenoids, taikugausins A-E (1-5), together with 5β,19-epoxy-25-methoxycucurbita-6,23-diene-3β,19-diol (6), have been isolated and characterized from the 70 % EtOH extract of the fresh fruits of Momordica charantia. The chemical structures of compounds 1-6 were elucidated on the basis of extensive spectroscopic analyses, especially 2D NMR (HMQC, HMBC, and NOESY) experiments and HRESIMS data. The relationship between NMR chemical shifts and the configuration of C-19 with an OMe group in 5β,19-epoxycucurbitane are described. Among them, compounds 3 and 4 exhibited remarkable anti-inflammatory activities by the inhibition of nitric oxide production at the concentration of 10 µg/mL. In addition, 3 and 4 also showed moderate cytotoxicity against WiDr, Hep G2, MCF-7, and HEp-2 human tumor cell lines. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25469855     DOI: 10.1055/s-0034-1383307

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  7 in total

1.  Cucurbitane-Type Triterpenoids from the Vines of Momordica charantia and Their Anti-inflammatory Activities.

Authors:  Hung-Tse Huang; Li-Jie Zhang; Hui-Chi Huang; Syh-Yuan Hwang; Chia-Lun Wu; Yu-Chi Lin; Chia-Ching Liaw; Yung-Yi Cheng; Susan L Morris-Natschke; Chung-Yi Huang; Kuo-Hsiung Lee; Yao-Haur Kuo
Journal:  J Nat Prod       Date:  2020-05-01       Impact factor: 4.050

Review 2.  Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.

Authors:  Komal Raina; Dileep Kumar; Rajesh Agarwal
Journal:  Semin Cancer Biol       Date:  2016-07-21       Impact factor: 15.707

3.  A triterpenoid from wild bitter gourd inhibits breast cancer cells.

Authors:  Li-Yuan Bai; Chang-Fang Chiu; Po-Chen Chu; Wei-Yu Lin; Shih-Jiuan Chiu; Jing-Ru Weng
Journal:  Sci Rep       Date:  2016-03-01       Impact factor: 4.379

4.  Anti-Inflammatory, Antidiabetic Properties and In Silico Modeling of Cucurbitane-Type Triterpene Glycosides from Fruits of an Indian Cultivar of Momordica charantia L.

Authors:  Wilmer H Perera; Siddanagouda R Shivanagoudra; Jose L Pérez; Da Mi Kim; Yuxiang Sun; Guddadarangavvanahally K Jayaprakasha; Bhimanagouda S Patil
Journal:  Molecules       Date:  2021-02-16       Impact factor: 4.411

Review 5.  A detailed review on the phytochemical profiles and anti-diabetic mechanisms of Momordica charantia.

Authors:  Sunday Faith Oyelere; Oluwatobi Hezekiah Ajayi; Titilayo Eunice Ayoade; George Bueno Santana Pereira; Bolaji Charles Dayo Owoyemi; Ajibola Olaoluwa Ilesanmi; Olalekan Amos Akinyemi
Journal:  Heliyon       Date:  2022-04-06

6.  Medically important carotenoids from Momordica charantia and their gene expressions in different organs.

Authors:  Do Manh Cuong; Mariadhas Valan Arasu; Jin Jeon; Yun Ji Park; Soon-Jae Kwon; Naif Abdullah Al-Dhabi; Sang Un Park
Journal:  Saudi J Biol Sci       Date:  2017-11-16       Impact factor: 4.219

7.  Cucurbitane-Type Triterpene Glycosides from Momordica charantia and Their α-Glucosidase Inhibitory Activities.

Authors:  Ya Gao; Jian-Chao Chen; Xing-Rong Peng; Zhong-Rong Li; Hai-Guo Su; Ming-Hua Qiu
Journal:  Nat Prod Bioprospect       Date:  2020-05-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.